SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513160-12-000050
Filing Date
2012-07-30
Accepted
2012-07-27 17:41:55
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 PHARMOS QUARTERLY REPORT pars10q06302012.htm 10-Q 366993
2 RULE 13A-14(A)/15D-14(A) CERTIFICATION ex311.htm EX-31.1 9433
3 RULE 13A-14(A)/15D-14(A) CERTIFICATION ex312.htm EX-31.2 8530
4 SECTION 1350 CERTIFICATION ex321.htm EX-32.1 5182
5 SECTION 1350 CERTIFICATION ex322.htm EX-32.2 4942
  Complete submission text file 0001513160-12-000050.txt   1321304

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pars-20120630.xml EX-101.INS 90871
7 XBRL TAXONOMY EXTENSION SCHEMA pars-20120630.xsd EX-101.SCH 12128
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pars-20120630_cal.xml EX-101.CAL 24963
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pars-20120630_def.xml EX-101.DEF 8173
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pars-20120630_lab.xml EX-101.LAB 82695
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pars-20120630_pre.xml EX-101.PRE 59987
Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830
Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 7324529556
PHARMOS CORP (Filer) CIK: 0000713275 (see all company filings)

IRS No.: 363207413 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-11550 | Film No.: 12991532
SIC: 2834 Pharmaceutical Preparations